Quick Links

Benitec Biopharma (ASX:BLT) has created a novel combination of gene therapy and RNA interference (gene silencing) to change treatment paradigms of human disease.

Why invest in Benitec?

See why investors are investing in Benitec's platform, strategy, pipeline and IP strength.

Investor FAQ

Can't find what you're looking for? Try our FAQ.

Stay updated today

Keep up with programs, reports, announcements and events.

Sign Up